The global fibrotic diseases treatment market is anticipated to grow at a CAGR of 6.0% during the forecast period (2022-2028). Fibrosis is a distinctive biochemical characteristic of majority of chronic inflammatory diseases. It is scarring that results out of the accumulation of excess extracellular matrix components. If highly progressive, the fibrotic process eventually leads to […]
